当前位置:
文档之家› 异常凝血酶原对肝细胞癌经肝动脉化疗栓塞术后短期疗效的评价价值 查俊豪
异常凝血酶原对肝细胞癌经肝动脉化疗栓塞术后短期疗效的评价价值 查俊豪
PIVKA - Ⅱ has a good value in monitoring the short - term efficacy of TACE in patients with HCC.
: , ; , ; ; Key words carcinoma hepatocellular chemoembolization therapeutic PIVKA - Ⅱ treatment outcome
具有便捷、无创、经济等优点。但迄今为止,我国关于 mRECIST标ቤተ መጻሕፍቲ ባይዱ[11]。根据强化的靶病灶最长径总和变化
PIVKA - Ⅱ在肝癌临床诊疗中的应用和研究尚未全面开 的百分比来定义:(1)完全缓解(complete , ), response CR
0 708,P 值均 < 0. 001) 。 配对 χ2 检验提示血清学反应与影像学反应评价方式敏感度较为一致( 术后 1、3、6 个月 χ2 值分别为 0、
结论 1 5、1. 5,P 值分别为 1. 000、0. 219、0. 219) 。 血清学反应的真实性和可靠性评价指标均维持在较高的水准。
基于影像学反应
, ( , , , ; ZHA Junhao1 GUO Jinhe2 . 1. Medical School Southeast University Nanjing 210009 China 2. Department of Interventional Radiology , , , ) and Vascular Surgery Zhongda Hospital Affiliated to Southeast University Nanjing 210009 China
摘要:目的 探讨异常凝血酶原( PIVKA - Ⅱ) 在肝细胞癌患者经肝动脉化疗栓塞术( TACE) 后短期疗效监测中的评价价值。 方法 回顾性分析 2019 年 1 月 - 12 月东南大学附属中大医院收治的 114 例肝细胞癌患者临床资料,患者单纯接受传统 TACE 治疗
且 PIVKA - Ⅱ基线数值≥40. 00 mAU / ml。 分析 TACE 术前与术后第 1、3、6 个月之间 PIVKA - Ⅱ血清学反应情况,并与同期影像学 反应( 采用 mRECIST 标准) 进行对照分析。 采用 Spearman 相关性分析探索血清学反应与同期影像学反应的相关性。 采用配对 χ2
: [ ( Abstract Objective To investigate the value of abnormal prothrombin protein induced by vitamin K absence or antagonist -Ⅱ PIVKA -
)] ( ) Ⅱ in monitoring the short - term efficacy of transcatheter arterial chemoembolization TACE in patients with hepatocellular carcinoma ( ) HCC . Methods A retrospective analysis was performed for the clinical data of 114 patients with HCC who were admitted to Zhongda , , Hospital Affiliated to Southeast University from January to December 2019 and all patients received conventional TACE alone and had a , , baseline PIVKA - Ⅱ level of ≥40. 00 mAU / ml. Serological response of PIVKA - Ⅱ was observed before TACE and at 1 3 and 6 months ( ) after TACE and was compared with radiological response at the same time point based on mRECIST guidelines . A Spearman correlation
1991
细胞发挥最大限度的杀伤作用[3 - 。5] TACE 的适应证涵 再次造影,在透视监视下依据肿瘤区碘油沉积是否浓密、
盖了Ⅰb 期至Ⅲb 期肝癌,是肝癌非手术切除治疗中应用 瘤周是否已出现门静脉小分支影为界限。
范围最广的一种治疗方法,可显著延长患者生存 1. 2. 2 数据收集 回顾性收集所有患者临床、实验室和
收 基 作 通DO稿 金 者 信I:日 项 简 作10期 目 介 者. 3::::92国 查 郭6092家 俊 金/0j.自 豪 和-is0s然(,n3电1.科9-1子900学406信1-;基修箱)-金,5回:男2j面5i日n,6上h主.期e2g项要0u:22o目从0@0.2(事00s89in1-肿.a600.71瘤4c16o7-介m905入2)专业研究
检验探索血清学反应与影像学反应评价方式敏感度的一致性。 以影像学反应为金标准,分析 PIVKA - Ⅱ血清学反应的真实性及可
结果 靠性评价指标。
纳 入 患 者 的 PIVKA - Ⅱ 水 平 为 7225. 44 ( 40. 13 ~ 30 000. 00 ) mAU / ml。 术 后 1、3、6 个 月, 分 别 有 104
(91 2% ) 、94(90. 3% ) 、86(90. 5% ) 例患者分为血清学有反应组,分别有 103(90. 3% ) 、90(86. 5% ) 、82(86. 3% ) 例患者分为影像
学有反应组。 Spearman 相关性分析提示,影像学反应与血清学反应呈 正 相关 ( 术 后 1、3、6 个 月对 应 r 值 分别 为 0. 739、0. 731、
目前,肝细胞癌是我国第四位的常见恶性肿瘤及第 三位的肿瘤致死病因[1 -2]。经肝动脉化疗栓塞术(tran , )一方面阻断肿 scatheter arterial chemoembolization TACE 瘤血供,同时在肿瘤局部聚集高浓度的化疗药物,对肿瘤
查俊豪,等. 异常凝血酶原对肝细胞癌经肝动脉化疗栓塞术后短期疗效的评价价值
1990
临床肝胆病杂志第 卷第期 年月 , , 36 9 2020 9 J Clin Hepatol Vol.36 No.9 Sep.2020
异常凝血酶原对肝细胞癌经肝动脉化疗栓塞术后 短期疗效的评价价值
查俊豪1,郭金和2
1 东南大学医学院,南京210009;2 东南大学附属中大医院介入与血管外科,南京210009
analysis was used to investigate the correlation between serological response and radiological response. The paired chi - square test was used to analyze the consistency between the sensitivity of serological response and that of radiological response. Radiological response was used as the gold standard to investigate the validity and reliability assessment indices of the serological response of PIVKA - Ⅱ. Results The pa
( ) , , , tients enrolled in this study had a PIVKA - Ⅱ level of 7225. 44 40. 13 - 30 000. 00 mAU / ml. At 1 3 and 6 months after TACE 104 ( ), ( ), ( ), , , patients 91. 2% 94 patients 90. 3% and 86 patients 90. 5% respectively had serological response while 103 patients ( ), ( ), ( ) 90 3% 90 patients 86. 5% and 82 patients 86. 3% had radiological response. The Spearman correlation analysis showed that ra , , ( , , , diological response was positively correlated with serological response at 1 3 and 6 months after TACE r = 0. 739 0. 731 and 0. 708 all ) P < 0 001 . The paired chi - square test showed that serological response and radiological response had a relatively consistent sensitivity in , , ( , , , , , ) assessment at 1 3 and 6 months after TACE χ2 = 0 1. 5 and 1. 5 P = 1. 000 0. 219 and 0. 219 . The validity and reliability assess , ment indices of serological response maintained at a relatively high level. Conclusion Based on the criteria for radiological response